antigen modification regulates competition broad narrow neutralizing hiv antibodies
hiv-infected individuals develop broadly neutralizing antibodies bnabs whereas develop antibodies neutralize narrow range viruses nnabs bnabs nnabs protect animals experimental infection likely key component effective vaccine nnabs bnabs target regions viral envelope glycoprotein env reasons remain unclear nnabs elicited env immunization show contrast germline-reverted gl bnabs glnnabs recognized diverse recombinant envs moreover owing binding affinity differences nnab b cell progenitors advantage becoming activated internalizing env compared bnab b cell progenitors identified env modification strategy minimized activation nnab b cells targeting epitopes overlap bnabs
